This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
CCL Healthcare has partnered with Controlant do develop an end-to-end IOT supply chain solution with real-time visibility for the pharmaceutical industry.
The Saga Card represents an IoT innovation aimed at enhancing supply chain transparency. It integrates a printed battery, cellular modem, and sensors to actively track medications throughout the supply chain. Real-time data provided by the cellular modem and sensors ensures compliance with FCC regulations. Additionally, the device automatically deactivates once the medication reaches its designated point of use.
The Saga card, assembled and finished by CCL through cutting-edge continuous manufacturing, enables global scalability. Incorporating advanced zinc-based (non-lithium) battery technology from CCL's subsidiary, Imprint Energy, the IOT device boasts an ultrathin (.6mm) profile while supporting LTE CAT M connectivity. Imprint Energy Batteries, renowned for their eco-friendliness and disposability, represent a pinnacle in sustainable energy solutions. Imprint Energery’s battery technology stands out as one of the most advanced and flexible options in the market, perfectly suited for a range of applications including smart labels, medical devices, pharmaceuticals, consumer electronics, and various other IOT devices.
"CCL plays a pivotal role in advancing the Saga Card's development. Drawing upon our extensive expertise in electronics manufacturing, we've engineered a continuous manufacturing solution and integrated our recently acquired battery company, Imprint Energy," explained Patrick Thomas, VP of Manufacturing at CCL.
Moreover, CCL Healthcare is actively engaged in refining the next iteration of the IoT device. This forthcoming version aims to improve various aspects, such as extending battery life and enhancing internal circuitry, to deliver cutting-edge IoT devices tailored for the pharmaceutical and medical device sector.